Luoxin Pharmaceuticals Group Stock Co., Ltd. Share Price
Equities
002793
CNE1000026S7
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 CNY | -0.46% | +6.93% | -19.40% |
Sales 2022 | 3.59B 495M 41.29B | Sales 2023 | 2.36B 326M 27.21B | Capitalization | 5.83B 805M 67.1B |
---|---|---|---|---|---|
Net income 2022 | -1.23B -169M -14.11B | Net income 2023 | -661M -91.23M -7.61B | EV / Sales 2022 | 2.93 x |
Net Debt 2022 | 2.17B 300M 24.99B | Net Debt 2023 | 798M 110M 9.19B | EV / Sales 2023 | 2.8 x |
P/E ratio 2022 |
-8.92
x | P/E ratio 2023 |
-8.79
x | Employees | 4,582 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.27% |
1 day | -0.46% | ||
1 week | +6.93% | ||
Current month | -6.09% | ||
1 month | -5.26% | ||
3 months | -14.46% | ||
6 months | -25.65% | ||
Current year | -19.40% |
Managers | Title | Age | Since |
---|---|---|---|
Zhen Teng Liu
CEO | Chief Executive Officer | 38 | 23/20/23 |
Xian Chen
DFI | Director of Finance/CFO | 41 | 08/21/08 |
Hong Yan Liu
BRD | Director/Board Member | 42 | 31/23/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Sheng Han
SEC | Corporate Secretary | 49 | 23/20/23 |
Liang Wei Song
CHM | Chairman | 44 | 31/23/31 |
Yun Pei Guo
BRD | Director/Board Member | 76 | 19/21/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 4.32 | -0.46% | 8,492,532 |
25/24/25 | 4.34 | +3.09% | 18,942,610 |
24/24/24 | 4.21 | -0.24% | 6,845,830 |
23/24/23 | 4.22 | +3.94% | 13,130,550 |
22/24/22 | 4.06 | +0.50% | 5,204,900 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.40% | 648M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002793 Stock